FEBRUARY 2024LIFE SCIENCES REVIEW5CXO INSIGHTSLAST WORD1821232628Andreas Søderman, Head of Medical Affairs, OrifarmRivka Krakofsky, Associate Director- Market Insights and Strategy, BeiGeneHong Ma MD, Sr Vice President of Clinical Development; Site head in Houston office, CARsgen Therapeutics and Jianguo Wen Ph.D., Srinath Palakurthi, Ph.D.Marc de Garidel, Chief Executive Officer, AbivaxRachel Legmann, PhD, Senior director of technology, gene therapy, Repligen CorpHead, Global Medical Analytics, Real World Evidence, and Health Economics & Outcomes Research,ViatrisThe Untapped Potential of Medical Affairs in Generics, Value added medicines and Hybrid pharmaceuticalsDriving Success in the Dynamic Pharma IndustryNovel Nanotechnology in CAR-T Therapy Targeting Solid TumorsLeveraging Technological Advancements for Developing Innovative TherapeuticsGene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and InnovationArtificial Intelligence and the Healthcare IndustryIN MY OPINION08The Next Technological Advancement in Resin DevelopmentSofie Stille, Vice President of Technology, Cytiva30
< Page 4 | Page 6 >